No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Devices
Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It provides Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient’s knee joint; Episealer implant, which is designed to fit anatomy and size of the lesion; Episealer toolkit; and Episealer Patellofemoral System, a system to treat osteoarthritis limited to the patellofemoral part of the knee joint. The company also offers Epioscopy to identify and visualize femoral knee joint cartilage and bone lesions, and tibia, as well as defects on the cruciate ligaments and menisci; Epiguide, a surgical drill guide; and µiFidelity, a web platform for order management, communication, personalized design, and surgical pre-planning. In addition, it is developing Episealer MTP implant, an implant for the MTP joint of the big toe in the foot. Further, the company offers Talus Osteotomy Guide (TOG) that is designed to fit on the patient’s distal tibia using CT and MRI images; MRI protocol to ensure correct damage assessment, 3D visualization, and device design; and Damage Marking Report (DMR) that enables 3D visualization of damage in the joint surface and underlaying bone defects, as well as other findings relevant when selecting the right treatment for the patient. The company was formerly known as Diamorph Medtech AB and changed its name to Episurf Medical AB (publ) in 2010. Episurf Medical AB (publ) was incorporated in 2008 and is based in Stockholm, Sweden.
episurf.comNo one on the platform currently holds EPIS-B.ST.
No tracked institution reports a position in EPIS-B.ST as of their last filing.
No one on the platform has traded EPIS-B.ST yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $25M | +86.8% | $-0.10 | $-0.10–$-0.10 | — | 1 |
| 2027 | $54M | +111.8% | $0.00 | $0.00–$0.00 | — | 1 |
| 2028 | $109M | +101.9% | $0.00 | $0.00–$0.00 | — | 0 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| EPIS-B.STEpisurf Medical AB | $0.07 | -5.18% | $57M | — |
| 2CUREX.ST2cureX AB (publ) | $0.42 | -12.13% | $11M | — |
| AINO.STAino Health AB (publ) | $0.20 | -6.19% | $40M | — |
| CMH.STChordate Medical Holding AB (publ) | $0.10 | -37.50% | $269962 | — |
| EXPRS2.STExpreS2ion Biotech Holding AB (publ) | $1.25 | +0.00% | $3M | — |
| GUARD.STGuard Therapeutics International AB (publ) | $1.47 | +0.00% | $30M | — |
| MODTX.STModus Therapeutics Holding AB | $0.41 | -5.31% | $37M | — |
Source: Financial Modeling Prep · peers by sector/industry